Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3034

Actual shortage: 241 (8%)
Anticipated shortage: 18 (1%)
Avoided shortage: 9 (0%)
Resolved: 2766 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

30 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-ESCITALOPRAM 20MG TABLET Resolved 2019-03-05 2019-03-09 77881
APO-ESCITALOPRAM 10MG TABLET Resolved 2019-03-05 2019-03-09 77878
APO-DUTASTERIDE 0.5MG CAPSULE Resolved 2019-03-05 2019-04-05 77875
APO-DILTIAZ CD 300MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2019-03-05 2019-11-05 77872
APO-ALPRAZ .5MG TABLET Resolved 2019-03-05 2019-09-05 77869
APO-HYDROMORPHONE CR 30MG CAPSULE (EXTENDED RELEASE) Resolved 2019-03-05 2020-04-04 77858
APO-HYDROMORPHONE CR 24MG CAPSULE (EXTENDED RELEASE) Resolved 2019-03-05 2020-04-04 77855
APO-HYDROMORPHONE CR 18MG CAPSULE (EXTENDED RELEASE) Resolved 2019-03-05 2020-04-04 77852
APO-HYDROMORPHONE CR 12MG CAPSULE (EXTENDED RELEASE) Resolved 2019-03-05 2020-04-04 77849
APO-VERAP TABLET 120MG 120MG TABLET Resolved 2019-02-24 2019-04-05 76746
APO-RASAGILINE 1MG TABLET Resolved 2019-02-24 2019-08-30 76743
APO-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2019-02-24 2020-11-03 76740
APO-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2019-02-24 2020-11-03 76735
APO-PRAZO TAB 1MG 1MG TABLET Resolved 2019-02-24 2019-04-08 76732
APO-OLANZAPINE 10.0MG TABLET Resolved 2019-02-24 2019-03-29 76729
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2019-02-24 2019-04-15 76726
APO-LEVOFLOXACIN 500MG TABLET Resolved 2019-02-24 2019-03-08 76723
APO-LEVETIRACETAM 750MG TABLET Resolved 2019-02-24 2019-04-26 76720
APO-IBUPROFEN 200MG TABLET Resolved 2019-02-24 2020-04-01 76717
APO-DILTIAZ CD 240MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2019-02-24 2019-07-12 76714

Showing 1941 to 1960 of 3034

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-TELMISARTAN 40MG TABLET Discontinued 2019-01-04 2019-01-04 71345
APO-BOSENTAN 125.0MG TABLET Discontinued 2019-01-04 2019-01-04 71342
APO-BOSENTAN 62.5MG TABLET Discontinued 2019-01-04 2019-01-04 71339
APO-RIZATRIPTAN RPD Discontinued 2019-01-04 2019-04-04 71334
APO-IRBESARTAN 300MG TABLET Discontinued 2019-01-04 2019-01-04 71237
APO-IRBESARTAN 150MG TABLET Discontinued 2019-01-04 2019-01-04 71234
APO-IRBESARTAN 75MG TABLET Discontinued 2019-01-04 2019-01-04 71231
NAPROXEN SODIUM TABLETS 220MG TABLET Discontinued 2019-01-04 2019-01-04 71228
ACETAMINOPHEN CAPLETS 500 MG 500MG TABLET Discontinued 2019-01-04 2019-01-04 71225
ACETAMINOPHEN CAPLETS 325 MG 325MG TABLET Discontinued 2019-01-04 2019-01-04 71222
ACETAMINOPHEN TABLETS USP 325 MG 325MG TABLET Discontinued 2019-01-04 2019-01-04 71219
ACETAMINOPHEN TABLETS USP 500 MG 500MG TABLET Discontinued 2019-01-04 2019-01-04 71216
APO-LOSARTAN 100MG TABLET Discontinued 2019-01-04 2019-01-04 71213
ACID REDUCER 150MG TABLET Discontinued 2019-01-04 2019-01-04 71210
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Discontinued 2019-01-04 2019-01-04 71207
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71204
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71201
ACID CONTROL Discontinued 2019-01-04 2019-01-04 71198
APO-CEFPROZIL 250MG TABLET Discontinued 2019-01-04 2019-02-21 71195
ACETAMINOPHEN HEADACHE ULTRA RELIEF 500MG 65MG TABLET Discontinued 2019-01-04 2019-01-04 71192

Showing 61 to 80 of 356